CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group.
Smith
Sidney C
SC
Anderson
Jeffrey L
JL
Cannon
Richard O
RO
Fadl
Yazid Y
YY
Koenig
Wolfgang
W
Libby
Peter
P
Lipshultz
Steven E
SE
Mensah
George A
GA
Ridker
Paul M
PM
Rosenson
Robert
R
D000209:Acute-Phase Proteins / Q000032:analysis; D015415:Biomarkers / Q000097:blood*; D002097:C-Reactive Protein / Q000032:analysis*; D002318:Cardiovascular Diseases / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control; D015815:Cell Adhesion Molecules / Q000097:blood; D018925:Chemokines / Q000097:blood; D016207:Cytokines / Q000097:blood; D003937:Diagnosis, Differential; D003955:Diagnostic Tests, Routine; D005260:Female; D006801:Humans; D007249:Inflammation / Q000097:blood / Q000150:complications / Q000175:diagnosis*; D008297:Male; D011237:Predictive Value of Tests; D015980:Public Health Practice; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D018570:Risk Assessment
D000209:Acute-Phase Proteins; D015415:Biomarkers; D015815:Cell Adhesion Molecules; D018925:Chemokines; D016207:Cytokines; D002097:C-Reactive Protein